In May, our team embarked on a business trip to South Korea to meet with several of our valued partners, including Dong-A Pharm, the country's foremost pharmaceutical research and development company.
During the visit, we engaged in productive discussions with Dong-A Pharm's leadership and R&D teams, exploring ways to deepen our collaboration. As a pioneer in drug development and innovation, Dong-A Pharm plays a critical role in advancing healthcare solutions, and we are honored to contribute to their success.
We look forward to continuing our collaboration with Dong-A Pharm and other industry leaders to drive innovation and create impactful solutions for global healthcare challenges.
During the visit, we engaged in productive discussions with Dong-A Pharm's leadership and R&D teams, exploring ways to deepen our collaboration. As a pioneer in drug development and innovation, Dong-A Pharm plays a critical role in advancing healthcare solutions, and we are honored to contribute to their success.
The trip also included meetings with other key clients, reinforcing our commitment to delivering excellence and fostering long-term partnerships in the South Korean market.
We look forward to continuing our collaboration with Dong-A Pharm and other industry leaders to drive innovation and create impactful solutions for global healthcare challenges.
Explore More — WeHereMedSolution.com
Solutions Trusted by Global Partners →Consumable supply programs for pharmaceutical and healthcare partners.
Related News
Oct 23, 2026
→
CMEF Autumn 2026: Walking the Show Floor in Beijing with Our Clients
On 23 October 2026, WeHere Medical accompanied international clients through the 94th CMEF in Beijing - ultrasound forums, surgical robotics demos and...
Oct 23, 2026
→
WeHere Medical Hosts Client at CMEF Beijing 2026: A Hands-On Partnership Meeting
WeHere Medical recently welcomed a valued client to Beijing for a hands-on demonstration and deeper partnership discussion during the 94 th China Inte...
Oct 21, 2026
→
EU MDR Revision: "Single-Use" Is Becoming a Claim, Not a Default
The European Commission's proposed MDR rewrite turns the single-use label into a claim that must be justified in the technical file. For makers of dis...